Health InsiderHealth Insider Facebook ad: “Skip Ozempic, Try This”
Ran for 26 days, from February 24 to March 22, 2026, the last day Crush saw it.
Run by Health Insider on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Make your own version of this ad
Crush makes it, launches it in your own Meta ad account, scales the winners and pauses the losers.
About this ad
- Meta Ad Library ID
- 1217114320409577
- Platforms
- Facebook, Instagram, Messenger and Threads
- Relaunches
- 0
Ad text
“Ozempic prescriptions are up 2,082% — and most people don’t understand the risks,” says endocrinologist Dr. Theresa Bell. She breaks down why nausea, stomach paralysis, and rebound weight are so common… and how boosting your natural GLP-1 may be a safer long-term solution. In this article, she compares the 3 top GLP-1-supporting supplements and reveals the one that outperforms the rest. Tap to read the doctor’s full review 👇
Where the ad sends people
healthinsider.news
Skip Ozempic — Try This
A doctor compares the top 3 supplements that mimic GLP-1 — without injections or side effects.
Learn more: healthinsider.news(opens in a new tab)
